Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2017-08-30

Clinical Trial Update: Diaphragmatic Breathing Exercise Improves Non-alcoholic Fatty Liver Disease [NA]

View source ↗

Summary

A clinical trial evaluating diaphragmatic breathing for non-alcoholic fatty liver disease has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Taipei Medical University WanFang Hospital | Conditions: Non-alcoholic Fatty Liver Disease | NA | Status: WITHDRAWN